Sarcopenic obesity, which refers to concurrent sarcopenia and obesity, is characterized by
decreased muscle mass, strength, and performance along with abnormally excessive fat …

Obesity is a growing public health problem worldwide, and GH and IGF-1 have been studied
as potential therapeutic targets for managing this condition. This review article aims to …

Simple Summary Obesity is associated with metabolic changes in the immunological tumour
infiltrate in breast cancer. The crosstalk between adipocytes, macrophages and …

Gestational diabetes mellitus (GDM) is a complex metabolic disorder that has short-and long-
term effects on maternal and offspring health. This study aimed to assess the impact of …

Objective Benzene, ethylbenzene, meta/para-xylene, and ortho-xylene, collectively referred
to as benzene, ethylbenzene, and xylene (BEX), constitute the main components of volatile …

Insulin-like growth factor 1 (IGF-1), primarily synthesized in the liver, was initially discovered
due to its capacity to replicate the metabolic effects of insulin. Subsequently, it emerged as a …

Obstructive sleep apnoea (OSA) and components of metabolic syndrome (MetS) are
inextricably connected. Considering the increasing burden of MetS and OSA, in the present …

Simple Summary The rise in worldwide uterine cancer is tied to increasing obesity,
influencing substances such as adipocytokines and insulin-like growth factors (IGFs) in the …

Recombinant human growth hormone therapy, which was introduced in the 1980s, is now
routine for children with advanced chronic kidney disease (CKD) who are exhibiting growth …

Background: Physiological changes of blood amino acids and acylcarnitines during healthy
child development are not well studied. The LIFE Child study offers a platform with a large …